WASHINGTON A Food and Drug Administration panel of doctors and scientists voted today to recommend that the regulatory agency approve over-the-counter sales of a weight-loss pill now sold only with a prescription.
GlaxoSmithKline Consumer Healthcare still needs final FDA approval before it can sell the nonprescription version of orlistat, a drug already marketed in prescription form as Xenical, to overweight adults as use as a weight-loss aid.
The FDA approved the prescription version of the fat-blocking pill made by Roche in 1999.
A joint FDA advisory committee voted 11-2 to recommend approval late Monday following a daylong hearing. The agency usually follows the recommendations of its outside panels of experts.
Currently, the FDA has not approved any nonprescription weight-loss drugs for sale.
Read more in later editions of The Blade and toledoblade.com.
Guidelines: Please keep your comments smart and civil. Don't attack other readers personally, and keep your language decent. Comments that violate these standards, or our privacy statement or visitor's agreement, are subject to being removed and commenters are subject to being banned. To post comments, you must be a registered user on toledoblade.com. To find out more, please visit the FAQ.